GastroIntestinal BioSciences

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)1 trial
• Liver cirrhosis1 trial
• Primary biliary cholangitis1 trial
• Ulcerative colitis1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Terminated1 trial

Lead sponsor

• Bristol-Myers Squibb1 trial
• Ipsen1 trial
• Takeda1 trial

Running trials

• Active, not recruiting

  A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06254950· Phase 2· Takeda· Source

• Recruiting

  A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

  NCT06016842· Phase 3· Ipsen· Source

  Contact: Ipsen Clinical Study Enquiries

Closed trials

• Terminated

  Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

  NCT04267393· Phase 2· Bristol-Myers Squibb· Source